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In theory, immunodiagnosis should be able to discrimi-
nate between latent and acute TB, because the immuno-
pathoogic nature of the disease means there must be
significant differences in either the type and/or magni-
tude of immune response that develop. But so far we
have not been able to pinpoint them. Our investigations
of immune responses after infection suggest that in a
substantial number of former TB patients, strong anti-
gen recognition persists at least 20 years post-treatment
without signs of recurrent illness. In addition, antigen-
specific CD4 and CD8 memory T-cells could be
detected for at least two years post-infection. In a study
published in 2001, we found that healthy household
contacts who responded most strongly to ESAT-6 were
more likely to progress to disease in a short time, but
others who showed changes in their X-rays (meaning
that they had been infected and even developed some
pathology) remained otherwise healthy. An important
question is whether this group is representative of nat-
ural latent infection. If that is so, similar people should
be detectable in the general population and so our team
looked at ESAT-6 responses in community controls. We
found that although the responses to ESAT-6 were
lower overall in the general population, a substantial
subgroup were strongly positive. Our team’s assumption
is that these individuals have latent disease.
Given the results of our research, we have developed a
model for analyzing latent TB infection. After initial
exposure, two-thirds of the individuals exposed to TB
do not apparently skin-test convert nor become ESAT-6
positive: if they have had an infection, early bacterial
growth was presumably arrested fairly quickly. It is not
possible to tell if they have latent TB because immuno-
logically, they cannot be distinguished from uninfected
individuals. Of the remaining individuals exposed,
roughly five percent experience early bacterial growth
that is not contained and, if not treated, progresses to
clinical illness. In the remainder, subsequent bacterial
growth is contained, symptoms abate, but latent infec-
tion is established and approximately two percent
experience re-activation of the disease at a later time.
The rest remain healthy, but have latent infection,
which is discernible because immunologically these indi-
viduals tend to express elevated levels of interferon-
gamma (IFN-g), interleukin-12 (IL-12), IL-4 and IL-482
and strongly recognize latency antigens. These indivi-
duals are the focus of intense study because they repre-
sent natural immunity in action.
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